The granting of a Notice of Allowance for a patent application is a critical step in securing intellectual property rights, which can significantly enhance a company's value and competitive edge. For Tenax Therapeutics, this development not only strengthens its product pipeline but also potentially opens up new markets and opportunities for partnerships or funding. Given the importance of patents in the biotech industry, this news is likely to be viewed positively by investors and could lead to a short-term increase in TENX's stock price.